We speculate that the upregulated NCF2 in BLCa activates the NF-κB/VEGFA pathway through NADPH oxidase/ROS signaling, and ultimately promote BLCa angiogenesis and metastasis but more data are needed to confirm our hypothesis. The gene discussed is NCF2; the disease is bladder transitional cell carcinoma.